Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T14:55:57.546Z.
Calculation as of: 2026-10-06T14:55:57.546Z.
Quote observation: 2026-10-06T14:55:24.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6a2f90c369cc2bba861e7882df5fb589e6a534c6c6a3ec3aca589af2a274c9b5
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Anteris Technologies Global Corp.
Market Cap
$692.29M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$708.19M
EV/FCF Ratio
4.38x
TTM Avg
7.12x
3Y Avg
7.74x
5Y Avg
9.53x
Market Cap
$664.67M
EV/FCF Ratio
13.07x
TTM Avg
10.66x
3Y Avg
30.61x
5Y Avg
30.61x
Market Cap
$726.83M
EV/FCF Ratio
N/A
TTM Avg
3.46x
3Y Avg
3.45x
5Y Avg
3.45x
Market Cap
$718.57M
EV/FCF Ratio
N/A
TTM Avg
1185.88x
3Y Avg
1179.74x
5Y Avg
1179.74x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Anteris Technologies Global Corp. (AVR) | $692.29M | N/A | N/A | N/A | N/A |
| Faeth Therapeutics, Inc. (FTH)vs › | $688.75M | N/A | N/A | N/A | N/A |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $699.65M | N/A | N/A | N/A | N/A |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $708.19M | 4.38x | 7.12x | 7.74x | 9.53x |
| Annexon, Inc. (ANNX)vs › | $676.72M | N/A | N/A | N/A | N/A |
| MiMedx Group, Inc. (MDXG)vs › | $664.67M | 13.07x | 10.66x | 30.61x | 30.61x |
| Helus Pharma Inc. (HELP)vs › | $663.54M | N/A | N/A | N/A | N/A |
| Achieve Life Sciences, Inc. (ACHV)vs › | $726.83M | N/A | 3.46x | 3.45x | 3.45x |
| Avalo Therapeutics, Inc. (AVTX)vs › | $718.57M | N/A | 1185.88x | 1179.74x | 1179.74x |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $654.94M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
